STRATA Skin Sciences (SSKN) stock price, revenue, and financials

STRATA Skin Sciences market cap is $58.8 m, and annual revenue was $23.09 m in FY 2020

$58.8 M

SSKN Mkt cap, 12-Nov-2021

$23.1 M

STRATA Skin Sciences Revenue FY, 2020
STRATA Skin Sciences Gross profit (FY, 2020)14.1 M
STRATA Skin Sciences Gross profit margin (FY, 2020), %61.2%
STRATA Skin Sciences Net income (FY, 2020)-4.4 M
STRATA Skin Sciences EBIT (FY, 2020)-4.1 M
STRATA Skin Sciences Cash, 31-Dec-202010.6 M
STRATA Skin Sciences EV59 M
Get notified regarding key financial metrics and revenue changes at STRATA Skin SciencesLearn more
Banner background

STRATA Skin Sciences Income Statement

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

11.3k75.8k69.1k144.1k144.4k107.7k97.6k225.2k217.9k81.2k611.0k8.3m7.6m7.7m7.8m7.3m8.7m7.5m6.5m7.5m7.9m7.5m7.7m7.5m6.7m4.0m

Cost of goods sold

130.4k372.0k568.9k1.1m1.4m2.0m918.5k1.3m1.6m710.9k6.5m3.0m3.4m3.1m3.1m2.7m3.2m3.3m3.3m3.5m3.0m2.9m2.8m2.9m2.3m2.1m

Gross profit

(119.2k)(296.3k)(499.8k)(936.2k)(1.2m)(1.9m)(820.9k)(1.1m)(1.3m)(629.7k)(5.9m)5.3m4.2m4.6m4.7m4.5m5.5m4.2m3.2m4.0m4.8m4.6m4.9m4.6m4.4m2.0m

Gross profit Margin, %

(1059%)(391%)(723%)(650%)(857%)(1735%)(841%)(467%)(616%)(775%)(960%)63%55%59%60%62%64%56%49%54%61%62%64%62%65%49%

Sales and marketing expense

3.7m3.5m2.8m3.2m3.1m2.7m2.9m2.4m2.5m3.1m3.0m2.9m3.0m1.4m

R&D expense

2.6m2.4m2.4m1.7m1.4m1.3m1.1m856.8k707.8k370.6k344.5k238.9k282.0k471.0k525.0k634.0k382.0k475.0k423.0k411.0k338.0k269.0k224.0k304.0k235.0k249.0k292.0k247.0k

General and administrative expense

2.2m3.7m3.2m3.5m3.5m4.3m4.7m3.5m3.2m2.8m2.3m2.8m910.0k4.0m2.1m1.9m1.9m1.6m1.7m1.7m1.8m2.3m2.2m2.5m2.7m2.2m2.1m1.9m

Operating expense total

4.8m6.1m5.7m5.2m4.9m5.5m5.8m4.3m3.9m3.2m2.7m3.0m3.1m7.6m6.3m6.1m5.1m5.2m5.2m4.8m5.0m5.0m4.9m5.9m5.9m5.4m5.3m3.6m

EBIT

(4.8m)(6.1m)(5.8m)(5.5m)(5.4m)(6.5m)(7.0m)(6.2m)(4.7m)(4.3m)(4.0m)(3.6m)(9.0m)(2.3m)(2.1m)(1.5m)(405.0k)(687.0k)309.0k(572.0k)(1.8m)(946.0k)(52.0k)(1.2m)(983.0k)(729.0k)(948.0k)(1.6m)

EBIT margin, %

(51301%)(7258%)(7765%)(4501%)(4870%)(5762%)(4847%)(1891%)(1836%)(4472%)(1474%)(28%)(28%)(19%)(5%)(9%)4%(8%)(28%)(13%)(1%)(17%)(13%)(10%)(14%)(40%)

Interest expense

48.8k291.6k3.2m4.9m1.7m3.6m1.2m6.9m767.0k2.0m1.0m1.3m1.4m13.1m342.0k369.0k318.0k135.0k145.0k153.0k1.0k18.0k

Interest income

13.9k10.7k13.4k9.0k5.9k2.1k2.7k2.5k618.0688.03.9k1.1k

Pre tax profit

(1.4m)559.0k(1.4m)(2.2m)(1.1m)(13.6m)(2.2m)(1.3m)(370.0k)(1.4m)(1.1m)(882.0k)(947.0k)(1.6m)

Income tax expense

66.0k61.0k64.0k70.0k73.0k38.0k40.0k40.0k(80.0k)(43.0k)(46.0k)(22.0k)88.0k47.0k

Net Income

(4.8m)(6.1m)(5.8m)(5.5m)(5.4m)(6.5m)(7.4m)(7.4m)(8.0m)627.0k(2.3m)(7.3m)(7.8m)(9.2m)(1.4m)498.0k(1.5m)(2.2m)(1.2m)(13.7m)(2.2m)(1.4m)(290.0k)(1.3m)(1.1m)(860.0k)(1.0m)(1.7m)

STRATA Skin Sciences Balance Sheet

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Cash

20.9m17.0m22.3m17.2m13.3m21.6m15.2m2.6m8.1m4.2m14.5m8.2m5.6m3.2m3.1m2.8m3.0m3.8m3.9m3.1m3.4m14.4m15.9m16.4m15.9m16.2m8.2m11.2m

Accounts Receivable

12.1k68.4k100.6k169.4k208.3k50.9k34.1k49.5k85.2k5.8k3.7m4.2m3.2m2.7m2.9m3.3m3.6m3.2m2.5m2.6m2.7m3.6m3.5m3.6m3.2m1.4m

Prepaid Expenses

934.0k859.7k816.2k664.5k619.5k876.5k747.4k665.1k465.1k332.3k617.2k350.2k678.0k596.0k377.0k252.0k266.0k804.0k373.0k209.0k1.4m828.0k670.0k430.0k630.0k525.0k487.0k430.0k

Inventories

400.4k473.5k656.6k437.0k276.5k271.6k5.6m3.9m5.4m5.2m3.4m3.9m4.2m3.8m3.2m2.7m3.5m3.5m3.0m2.4m2.5m3.1m3.6m3.6m3.5m3.5m

Current Assets

21.9m17.9m23.5m18.4m14.7m23.1m16.4m3.6m14.3m8.5m20.5m13.9m13.4m12.0m10.9m9.6m9.4m10.5m11.4m10.1m10.3m20.3m21.8m23.5m23.7m24.0m22.8m23.9m

PP&E

1.8m1.7m2.4m3.2m5.2m8.5m10.0m9.4m3.0m3.9m2.7m1.6m14.8m14.5m12.8m11.6m10.8m10.0m9.4m8.7m6.9m6.3m5.7m5.0m4.8m4.6m5.4m5.0m

Goodwill

8.0m8.9m8.9m8.8m8.8m8.8m8.8m8.8m8.8m8.8m8.8m8.8m8.8m8.8m8.8m8.8m

Total Assets

24.2m20.3m26.1m21.9m20.1m31.8m26.6m13.1m17.4m12.5m24.3m16.2m54.4m52.2m47.5m44.4m43.0m43.2m42.9m39.9m36.8m45.7m46.2m47.7m48.0m47.5m46.0m46.2m

Accounts Payable

645.6k630.0k940.1k1.3m1.3m1.1m1.8m1.4m1.3m1.1m1.3m1.3m4.8m4.2m3.5m2.6m1.9m2.2m2.3m1.9m2.7m1.5m1.7m2.0m2.1m2.0m2.1m2.5m

Short-term debt

8.8m857.0k2.6m3.4m1.9m3.4m1.0m1.8m2.5m7.6m8.4m

Current Liabilities

1.3m1.3m1.6m2.4m2.4m2.3m3.7m2.6m10.9m5.2m4.0m3.9m16.6m15.3m5.6m4.4m4.6m7.6m8.4m6.1m9.0m4.3m4.8m10.1m11.1m12.2m16.8m16.6m

Long-term debt

6.0m5.0m4.7m7.2m11.3m11.3m10.5m8.9m8.2m8.8m6.9m7.3m7.4m6.9m7.0m6.1m988.0k2.6m

Non-Current Liabilities

121.3k129.7k139.6k181.6k210.5k6.1m5.3m231.3k138.9k114.9k5.1m4.8m

Total Debt

6.0m5.0m4.7m54.0k39.0k11.5m11.4m11.4m11.5m11.6m10.8m10.3m7.3m7.4m7.4m7.5m7.5m8.6m11.1m

Total Liabilities

1.4m1.4m1.7m2.6m2.6m8.4m9.1m2.9m11.0m5.3m9.1m8.7m27.2m36.3m32.5m27.1m27.1m30.6m31.3m15.9m16.9m12.4m12.8m17.5m18.5m18.7m18.0m19.4m

Common Stock

25.3k25.3k30.3k30.3k31.3k43.0k43.1k43.1k52.1k5.2k5.2k7.5k9.0k10.0k11.0k11.0k11.0k2.0k3.0k3.0k4.0k30.0k30.0k31.0k33.0k33.0k34.0k34.0k

Preferred Stock

1.2k1.2k1.2k1.0k1.0k1.0k1.0k1.0k1.0k1.0k4.0k

Additional Paid-in Capital

131.7m133.8m149.7m150.1m153.7m172.1m173.6m173.8m182.4m182.6m193.0m197.1m224.6m222.5m223.7m225.4m225.6m225.4m225.6m251.6m251.7m266.5m266.9m242.3m242.6m242.9m243.6m244.0m

Retained Earnings

(108.9m)(115.0m)(125.3m)(130.8m)(136.1m)(148.7m)(156.1m)(163.5m)(176.1m)(175.5m)(177.8m)(189.6m)(197.4m)(206.6m)(208.7m)(208.2m)(209.7m)(212.8m)(214.0m)(227.7m)(231.9m)(233.2m)(233.5m)(212.1m)(213.2m)(214.0m)(215.6m)(217.3m)

Total Equity

22.8m18.8m24.4m19.3m17.6m23.4m17.5m10.3m6.4m7.1m15.2m7.5m27.3m15.9m15.0m17.3m15.9m12.6m11.6m23.9m19.8m33.3m33.4m30.2m29.5m28.9m28.0m26.8m

Debt to Equity Ratio

0.3 x0.3 x0.6 x0 x0 x0.8 x0.7 x0.7 x0.9 x1 x0.5 x0.5 x0.2 x0.2 x0.2 x0.3 x0.3 x

Debt to Assets Ratio

0.2 x0.2 x0.3 x0 x0 x0.2 x0.3 x0.3 x0.3 x0.3 x0.3 x0.3 x0.2 x0.2 x0.2 x0.2 x0.2 x

Financial Leverage

1.1 x1.1 x1.1 x1.1 x1.1 x1.4 x1.5 x1.3 x2.7 x1.7 x1.6 x2.2 x2 x3.3 x3.2 x2.6 x2.7 x3.4 x3.7 x1.7 x1.9 x1.4 x1.4 x1.6 x1.6 x1.6 x1.6 x1.7 x

STRATA Skin Sciences Cash Flow

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Net Income

(9.8m)(15.9m)(5.8m)(11.2m)(16.6m)(6.5m)(13.9m)(21.3m)(8.0m)(7.4m)(9.6m)(7.3m)(15.1m)(24.4m)(1.4m)(939.0k)(2.4m)(2.2m)(3.4m)(17.1m)(2.2m)(3.6m)(3.9m)(1.3m)(2.4m)(3.3m)(1.0m)(2.7m)

Depreciation and Amortization

283.8k415.6k148.0k330.4k583.1k496.7k1.1m1.8m696.8k881.5k1.4m316.2k641.0k2.3m1.7m3.3m4.8m1.1m3.2m4.8m1.4m2.7m4.0m1.2m2.3m3.4m1.0m2.0m

Accounts Receivable

(12.1k)(68.4k)(100.6k)(29.4k)(68.6k)76.9k22.3k7.0k(28.8k)214.1k239.0k(300.0k)782.0k1.3m1.0m102.0k(147.0k)130.0k650.0k710.0k361.0k(175.0k)(85.0k)(261.0k)1.2m3.0m

Inventories

(310.1k)(383.2k)(566.3k)238.6k74.1k79.0k(16.8k)21.5k(1.4m)112.9k5.0m(295.0k)(24.0k)374.0k899.0k147.0k(670.0k)(716.0k)(20.0k)596.0k521.0k(327.0k)(813.0k)(792.0k)(444.0k)(443.0k)

Accounts Payable

(419.5k)(366.6k)75.4k888.8k773.9k(834.3k)225.0k(503.3k)(192.1k)(903.4k)(40.6k)(110.4k)204.0k289.0k(955.0k)(1.8m)(2.6m)354.0k403.0k71.0k381.0k(895.0k)(614.0k)281.0k327.0k233.0k222.0k571.0k

Cash From Operating Activities

(9.5m)(13.5m)(5.3m)(9.2m)(14.2m)(6.1m)(10.5m)(15.5m)(7.1m)(11.0m)(14.7m)(3.2m)(5.7m)(7.0m)(1.4m)(1.6m)(1.1m)818.0k1.7m2.2m60.0k(68.0k)1.8m336.0k406.0k1.1m598.0k1.2m

Purchases of PP&E

(30.8k)(58.7k)(408.1k)(1.4m)(3.7m)(1.6m)(3.8m)(4.9m)(42.5m)(42.5m)

Capital Expenditures

(200.0k)(206.0k)(321.0k)(6.0k)(6.0k)(6.0k)(5.0k)(5.0k)

Cash From Investing Activities

(30.8k)(58.7k)(408.1k)(1.4m)(3.7m)(1.6m)(3.8m)(4.9m)6.0k17.0k(42.6m)(43.6m)(182.0k)(188.0k)(467.0k)(883.0k)(1.5m)(1.9m)(405.0k)(914.0k)(1.3m)(434.0k)(952.0k)(1.4m)(596.0k)(730.0k)

Short-term Borrowings

(5.0k)(20.0k)(105.0k)(207.0k)(299.0k)(100.0k)(201.0k)(304.0k)(105.0k)(3.3m)(357.0k)

Long-term Borrowings

(6.4m)(857.0k)(3.0m)

Cash From Financing Activities

29.0k(165.6k)3.1m21.5m21.6m15.1m11.5m11.5m25.3m42.4m42.3m1.4m1.3m1.2m(100.0k)(201.0k)(1.2m)(307.0k)11.4m11.3m2.5m

Net Change in Cash

(9.6m)(13.5m)(5.7m)(10.8m)(14.7m)13.8m7.3m(5.2m)4.3m419.4k10.7m(3.2m)(5.9m)(8.3m)(183.0k)(462.0k)(346.0k)(165.0k)10.0k(801.0k)(652.0k)10.4m11.8m(98.0k)(546.0k)(259.0k)2.0k3.0m

Interest Paid

139.0k250.0k402.0k442.0k980.0k1.5m540.0k1.1m1.9m276.0k691.0k808.0k201.0k404.0k604.0k52.0k103.0k

Free Cash Flow

(1.1m)618.0k1.5m1.9m54.0k(74.0k)1.8m336.0k401.0k1.1m

STRATA Skin Sciences Ratios

USDQ2, 2011

Financial Leverage

1.1 x

STRATA Skin Sciences Employee Rating

2.79 votes
Culture & Values
2.6
Work/Life Balance
3
Senior Management
3
Salary & Benefits
2.6
Career Opportunities
2.6
Source